Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Prenol Lipids [PR] (W) --> Isoprenoids [PR01]--> C15 isoprenoids (sesquiterpenes) [PR0103]--> Acyclic farnesane sesquiterpenoids [PR010301]
LM_IDCommon NameSystematic NameFormulaMass
LMPR0103010000Farnesane skeleton---
LMPR01030100012E,6E-farnesol (W)2E,6E-farnesolC15H26O222.1984
LMPR0103010002Farnesyl diphosphate (W)Farnesyl pyrophosphateC15H28O7P2382.1310
LMPR0103010003Nerolidyl diphosphateNerolidyl pyrophosphateC15H28O7P2382.1310
LMPR0103010004Juvenile hormone III (W)-C16H26O3266.1882
LMPR0103010005Nerolidol (W)-C15H26O222.1984
LMPR01030100062E,6Z-farnesol3,7,11-trimethyldodeca-2E,6Z,10-trien-
1-ol
C15H26O222.1984
LMPR01030100072E,6Z-farnesal3,7,11-trimethyldodeca-2Z,6E,10-trienalC15H24O220.1827
LMPR0103010008(2-cis,6-cis)-farnesol(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-
trien-1-ol
C15H26O222.1984
LMPR01030100092-cis,6-cis-farnesyl diphosphate(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-
trien-1-yl trihydrogen diphosphate
C15H28O7P2382.1310
LMPR01030100102-cis,6-trans-farnesyl diphosphate(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-
trien-1-yl trihydrogen diphosphate
C15H28O7P2382.1310
LMPR01030100112-trans,6-cis-farnesyl diphosphate(2E,6Z)-3,7,11-trimethyldodeca-2,6,10-
trien-1-yl trihydrogen diphosphate
C15H28O7P2382.1310
LMPR0103010012(2-trans,6-trans)-farnesal(2E,6E)-3,7,11-trimethyldodeca-2,6,10-
trienal
C15H24O220.1827
LMPR0103010013(2-cis,6-trans)-farnesol3,7,11-trimethyldodeca-2Z,6E,10-trien-
1-ol
C15H26O222.1984
LMPR010301001414:0(5Me[R],9Me[R],13Me)5R,9R,13-trimethyl-tetradecanoic acidC17H34O2270.2559
LMPR010301001518:1(5Z)(9Me,13Me,17Me)9,13,17-trimethyl-5Z-octadecenoic acidC21H40O2324.3028
LMPR010301001620:1(5Z)(11Me,15Me,19Me)11,15,19-trimethyl-5Z-eicosenoic acidC23H44O2352.3341
LMPR010301001722:1(5Z)(13Me,17Me,21Me)13,17,21-trimethyl-5Z-docosenoic acidC25H48O2380.3654
LMPR010301001820:2(5Z,9Z)(11Me,15Me,19Me)11,15,19-trimethyl-5Z,9Z-eicosadienoic
acid
C23H42O2350.3185
LMPR010301001922:2(5Z,9Z)(13Me,17Me,21Me)13,17,21-trimethyl-5Z,9Z-docosadienoic
acid
C25H46O2378.3498
LMPR010301002020:3(5Z,9Z,17Z)(11Me,15Me,19Me)11,15,19-trimethyl-5Z,9Z,17Z-
eicosatrienoic acid
C23H40O2348.3028
LMPR010301002122:3(5Z,9Z,19Z)(13Me,17Me,21Me)13,17,21-trimethyl-5Z,9Z,19Z-
docosatrienoic acid
C25H44O2376.3341
LMPR010301002224:3(5Z,9Z,17Z)(15Me,19Me,23Me)15,19,23-trimethyl-5Z,9Z,17Z-
tetracosatrienoic acid
C27H48O2404.3654
LMPR0103010023farnesyl triphosphate3,7,11-trimethyldodeca-2,6,10-trien-1-
yl tetrahydrogen triphosphate
C15H29O10P3462.0974
LMPR0103010024-13-bromo-10R,11R-dichloro-7,11-
dimethyl-3-methylene-4-oxo-6E,8E,12E-
tridecatrienoic acid
C16H19BrCl2O3407.9895
LMPR0103010025-13-bromo-10S,11R-dichloro-7,11-
dimethyl-3-methylene-4-oxo-6E,8E,12E-
tridecatrienoic acid
C16H19BrCl2O3407.9895
LMPR0103010026-10S,11R-dichloro-7,11-dimethyl-3-
methylene-4R-hydroxy-6E,8E,12-
tridecatrienoic acid
C16H22Cl2O3332.0946
LMPR0103010027-13-bromo-10R,11R-dichloro-7,11-
dimethyl-3-methylene-4R-hydroxy-6E,8E,
12E-tridecatrienoic acid
C16H21BrCl2O3410.0051
 

logo LIPID MAPS is funded by a Wellcome Trust.